Literature DB >> 28318056

Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.

Igor Vázquez-Osorio1, Anna Duat-Rodríguez2, Francisco Javier García-Martínez3, Antonio Torrelo3, Lucero Noguera-Morel3, Angela Hernández-Martín3.   

Abstract

BACKGROUND/
OBJECTIVES: Mosaic neurofibromatosis type 1 (MNF1) is a variant of neurofibromatosis type 1 (NF1) in which clinical manifestations are limited to one or several body segments. The objective was to characterize the cutaneous features and associated systemic findings in a cohort of children with MNF1.
METHODS: We performed a retrospective study of 40 children diagnosed with MNF1 at the Department of Dermatology, Hospital Infantil Niño Jesús, Madrid, Spain, from January 1, 1986, to October 31, 2015.
RESULTS: All patients had pigmentary changes, alone (n = 39) or in combination with neurofibromas (n = 1). Twenty-four cases fulfilling the definition of MNF1 had six or more café au lait spots with or without freckling within the affected segment. They all lacked any other National Institutes of Health criteria of NF1. No patient had juvenile xanthogranuloma (JXG) or nevus anemicus (NA). Two children with MNF1 had epilepsy and two others developed malignancy (Hodgkin's lymphoma and ganglioneuroblastoma).
CONCLUSIONS: Pigmentary changes are the most frequent presentation of MNF1 in children. MNF1 must be considered with segmentary distribution of freckling and café au lait spots. Other frequent cutaneous findings in NF1, such as JXG or NA, seem to be exceptional in MNF1. Although the possibility of systemic complications and cancer risk seem to be low, patients must be followed up.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28318056     DOI: 10.1111/pde.13094

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Somatic TP53 variants frequently confound germ-line testing results.

Authors:  Jeffrey N Weitzel; Elizabeth C Chao; Bita Nehoray; Lily R Van Tongeren; Holly LaDuca; Kathleen R Blazer; Thomas Slavin; D A B M D Facmg; Tina Pesaran; Christina Rybak; Ilana Solomon; Mariana Niell-Swiller; Jill S Dolinsky; Danielle Castillo; Aaron Elliott; Chia-Ling Gau; Virginia Speare; Kory Jasperson
Journal:  Genet Med       Date:  2017-11-30       Impact factor: 8.822

2.  Neurofibromatosis Type I and Hodgkin Lymphoma: Case Report and Review of the Literature.

Authors:  Ülkü Miray Yıldırım; Rejin Kebudi
Journal:  Turk Arch Pediatr       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.